Channel - UNC Ethiopia Alliance
5/6/2021 4:10:36 PM

Channel Videos

Acute Myeloid Leukemia (AML): Finally Making Progress? - J. Zeidner - 20180523
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development.
UNCCN Mediasite Presenter
5/23/2018 3:30:00 PM
View

Acute Myeloid Leukemia: An Overview and Updates - M. Foster - 20170222
This presentation provides information to assist clinicians in identifying patients with Acute Myeloid Leukemia and selecting appropriate treatment options based on clinical and genetic variables. The presentation also reviews appropriate criteria for investigational/novel therapies and non-cytotoxic therapies, including stem cell transplantation, using cytogenetics and other variables. Lecture Objective: -Differentiate, among patients with Acute Myeloid Leukemia, those with favorable, intermediate, or unfavorable disease biology based on clinical, cytogenetic, and molecular genetic variables. -Identify patients with Acute Myeloid Leukemia likely to benefit from cytotoxic induction chemotherapy, and those unlikely to benefit from induction chemotherapy who are candidates for investigational or non-cytotoxic therapies. -Select appropriate patients with Acute Myeloid Leukemia for referral to consider stem cell transplantation. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Matthew Foster MD
2/22/2017 4:30:00 PM
View

Adolescent and Young Adult (AYA) Oncology - L. Sherwood - 20140910
The lecture will discuss an Oncology Review Group consisting of patients who were aged 15-39 at the time of initial cancer diagnosis (AYAs- Adolescents and Young Adults with Cancer). The research demonstrates differences in outcomes for AYA's with hematological cancers treated on pediatric vs. adult protocols. Learning Outcomes: 1. The participant will be knowledgeable of the NCCN guidelines for Adolescents and Young Adults with Cancer 2. The participant will be able to identify 3 areas of concern for Young Adults with Cancer 3. The participant will be able to refer Young Adults with Cancer to resources specifically for this age group. This lecture was presented as a part of the RN and Allied Health Series.
Liz Sherwood RN, MS, ANP-C
9/10/2014 3:55:00 PM
View

Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits - B. Wood and C. Battaglini - 20181024
In this presentation, Dr. Wood and Dr. Battaglini will review the importance of physical function (also referred to as physical performance) in patients receiving treatment for cancer, followed by a review of the mechanisms and evidence base supporting the role of exercise in improving cancer outcomes. Examples of aerobic and resistance exercise interventions will be discussed.
Claudio Battaglini PhD
10/24/2018 3:30:00 PM
View

Benefits of Regional Anesthesia in Cancer Surgery - D. James - 20200923
Dr. James from the UNC Anesthesiology Department in affiliation with UNC Lineberger cancer treatment group, will describe effects of regional and neuraxial perioperative blocks on cancer outcomes. Additional topical management considerations or recommendations for this patient population may also be presented.
UNCCN Mediasite Presenter
9/23/2020 3:30:00 PM
View

Benefits of Social Support Systems for Cancer Patients - C. Rini - 20160413
This presentation will talk about the importance of social support systems for Cancer patients. The speaker will discuss the challenges of getting and giving support and provide some potential strategies for achieving this goal. Learning Outcomes: • Assess different types and sources of social support. • Identify reasons why getting and giving social support is a complicated activity. • Employ potential strategies for helping ensure that patients get effective support that provides them with the emotional and practical coping assistance they need. This lecture was presented as a part of the RN and Allied Health Series.
Christine Rini PhD
4/13/2016 3:30:00 PM
View

Best of ASH 2018: Myeloma and Leukemia - B. Reeves & M. Foster - 20180123
Each year, the American Society of Hematology (ASH) hosts a conference highlighting some of the latest hematologic oncology research. Join us as our speakers discuss some of the top presentations on Myeloma and Leukemia/MDS from this year’s ASH conference.
UNCCN Mediasite Presenter
1/23/2019 4:30:00 PM
View

Cancer in Pregnancy - P. A. Gehrig - 20191127
To discuss the management of cervical cancer and cervical dysplasia in pregnancy and the impact of each condition on the other. To discuss the management of pelvic masses and ovarian cancer in pregnancy and the impact of each condition on the other.
UNCCN Mediasite Presenter
11/27/2019 4:30:00 PM
View

Cancer Pain Management - D. L. James - 20160525
This lecture will discuss the epidemiology and pathophysiology of cancer pain and focus on the principles of multimodal analgesia. Dr. James will also elucidate novel therapies in cancer pain management. Learning Outcomes: • Discuss epidemiology and pathophysiology of cancer pain. • Explain principles of multimodal analgesia. • Elucidate novel therapies in cancer pain management. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Dominika L James MD
5/25/2016 3:30:00 PM
View

Cancer-Related Cognitive Impairment: More Than a Side Effect of Chemotherapy - Z. Nakamura - 03132019
Cancer can impair a patient’s ability to think and to remember. While this condition is often called ‘chemo-brain,’ cognitive impairment stemming from cancer affects patients who might not have had either chemotherapy or radiation therapy. Dr. Nakamura will review our latest understandings of this condition.
Zev Nakamura, MD
3/13/2019 3:30:00 PM
View

Cardiovascular toxicity of targeted cancer therapies: Clinical considerations and potential mechanisms - B. Jensen - 20190925
When there is damage to the heart muscle, we call this cardiotoxicity. Brian Jensen, MD, will talk about underlying mechanisms for the cardiotoxicity of kinase inhibitors used to treat cancer.
UNCCN Mediasite Presenter
9/25/2019 3:30:00 PM
View

Caring for Adolescents and Young Adults Living with Cancer: Meeting their Unique Medical and Psychosocial Needs - L. Lux - 20181114
Adolescents and Young Adult living with cancer have unique medical and psychosocial needs. The recognition of these needs has created a new field of study in practice in the oncology world. As such many institutions are developing multidisciplinary teams to address AYA needs. However, you don't need a huge budget or a new program to make an impact with this age group. We will establish the age specific needs of this group and discuss some simple changes to make in your day to day practice that will help you meet your AYA patients' needs.
UNCCN Mediasite Presenter
11/14/2018 4:30:00 PM
View

Compassion Fatigue and Self-Compassion - M. Alvarez - 20150610
This discussion will talk in-depth about the physical and mental toll that caring for cancer patients takes on the caregiver. Learning Outcomes: 1. At the end of this session, participants will be able to identify the signs of compassion fatigue, secondary stress and burnout 2. Define the concept of self-compassion 3. Identify ways to mitigate compassion fatigue in four domains (physical, emotional, cognitive and spiritual) This lecture was presented as a part of the RN and Allied Health Series.
UNCCN Mediasite Presenter
6/10/2015 3:30:00 PM
View

Delivering Survivorship Care in North Carolina - D. Mayer - 20200513
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made, according to a commentary in the Journal of the National Cancer Institute. Dr. Mayer will discuss these issues with particular consideration to providing cancer survivorship care in North Carolina.
UNCCN Mediasite Presenter
5/13/2020 3:30:00 PM
View

Handling Difficult Situations & Conversations with Patients - D. Zolnoun - 20160113
Properly communicating with patients regarding their care and needs plays a vital role in their recovery. Become familiar with different type of difficult situations when dealing with patients including social, personal, and medical and how to develop your own successful style. Learning Outcomes: • Become familiar with the types of difficult situations: social vs. personal vs. medical • Gain insight into your own perceptions/comfort, and how it affects your ability to meet your objective of addressing patients' needs • Gain confidence in developing your individual style This lecture was presented as a part of the RN and Allied Health Lectures
Denniz Zolnoun MD, MPH
1/13/2016 4:30:00 PM
View

Immune (check point) Related Adverse Events - F. Collichio - 20200325
Dr. Frances Collichio from the UNC Lineberger Melanoma group will describe relevant updates in understanding and managing toxicities of immunotherapies for health care providers throughout the state of North Carolina.
UNCCN Mediasite Presenter
3/25/2020 3:30:00 PM
View

Immunotherapy 101 - P. Armistead - 20180912
This lecture will review the mechanisms by which the immune system in controlling both infections and cancer as well as strategies cancers have for evading effective immune responses and progressing. The lecture will also discuss the different types of currently available cancer immunotherapy treatments, their mechanisms of action and their potential side effects. — RN and Allied Health lectures offer FREE CNE and ASRT continuing education credit (upon approval) for eligible participants.
Paul Armistead MD
9/12/2018 3:30:00 PM
View

Improving End-of-Life Care: What can we learn from the bereaved? - D. L. Rosenstein and J. M. Yopp - 20180314
For the past eight years, Dr. Rosenstein and Dr. Yopp have run a support group for widowed fathers and conducted clinical research on this bereaved population. In this talk, they will briefly review the literature on studies of bereaved subjects, their research findings, and lessons learned from these studies.
Donald Rosenstein MD
3/14/2018 3:30:00 PM
View

Incorporating Palliative Care, Hospice, and End of Life Care in Oncology Practice - M. Dunn - 20150211
There are times when death is an inevitable topic that needs to broached with your patients. The desire for a "good death" can give patients a sense of control and strengthen relationships with loved ones. This lecture will go into the importance of incorporating this into the oncology practice. Learning Outcomes: 1. Identify end of life & palliative care resources around the state. 2. Identify medical & surgical palliative care interventions. 3. Identify the benefits of palliative care intervention throughout the trajectory of cancer care. This lecture was presented as a part of the RN and Allied Health Series.
Mary Dunn RN, MSN, OCN, NP-C
2/11/2015 4:55:00 PM
View

Infections in Cancer Patients - D. V. Duin - 20161116
This lecture discusses infections in cancer patients, including practice guidelines for management of neutropenia and hematopoietic stem cell transplantation. This presentation also discusses antibiotic resistance, antimicrobial stewardship, and infection control relevant to patients with cancer. Learning Outcomes: • Describe the epidemiology of infections in patients with cancer. • Discuss risk factors for infection in patients with cancer. • Identify methods of decreasing risk of infection in patients with cancer. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
David van Duin MD, PhD
11/16/2016 4:30:00 PM
View

Key 2018/2019 Developments in Lymphoma and Thrombosis/ Anticoagulation - S. Moll & A. Beaven - 20190227
Each year, the American Society of Hematology (ASH) hosts a conference highlighting some of the latest hematologic oncology research. Join us as our speakers highlight some of the top presentations on Non-Malignant Hematology and Lymphoma from this year’s ASH conference.
Stephan Moll MD
2/27/2019 4:30:00 PM
View

Late Effects of Childhood Cancer - J. Blatt - 20150722
This lecture will discuss the latent systemic effects for childhood cancer survivors. Dr. Julie Blatt explains how every organ is essentially at risk dependent upon type of treatment, age, and gender. Learning Outcomes: • to recognize the high cure rate in children with cancer • to describe the spectrum of possible late effects • to explain the role of the PCP and dedicated survivorship clinic in monitoring late effects This lecture was presented as a part of the Medical and Surgical Oncology Series.
UNCCN Mediasite Presenter
7/22/2015 3:30:00 PM
View

Management of Acute Myeloid Leukemia in 2020: A Paradigm shift for Older Adults? - J. Zeidner - 20200226
Dr. Joshua Zeidner will discuss updates in the diagnostic testing and prognostic subclassifications of AML which drive therapeutic decisions. This presentation will highlight perceived paradigm shifts for AML and older adults.
UNCCN Mediasite Presenter
2/26/2020 4:30:00 PM
View

Managing Chemotherapy Side Effects: Reviewing Prevention and Treatment Strategies of Three Common Issues - M. Gardiner - 20200812
Dr. Michelle Gardiner will discuss topics relevant to common and problematic side effects of anti-cancer treatments. Issues to be covered include; handling of acute infusion reactions, prevention and treatment of peripheral neuropathy, and the importance of recognizing and evaluating cancer-related fatigue in patients.
UNCCN Mediasite Presenter
8/12/2020 3:30:00 PM
View

Managing the Side Effects of Chemotherapy - M. Gardiner - 20161012
This lecture discusses the management of common chemotherapy-induced side effects and complications. The lecture includes a review of current guidelines for management of chemotherapy-induced nausea and vomiting and gives practical recommendations for other gastrointestinal side effects, including diarrhea, constipation, mucositis, and hiccups. There is also discussion of white blood cell growth factors, including appropriate use of these agents for cancer patients. Learning Outcomes: • Identify an appropriate regimen for prevention and treatment of chemotherapy-induced nausea and vomiting. • Discuss a self-care plan for management of gastrointestinal related side effects. • Explain appropriate use of white blood cell growth factors. The lecture was presented as part of the RN and Allied Health Lecture Series.
Michelle Gardiner PharmD, BCOP
10/12/2016 3:30:00 PM
View

Nutrition Update: Prevention, Treatment and Recovery - J. Spring - 20170308
This presentation provides information to assist health care provider sin identifying the role of nutrition in cancer. The presentation reviews the evidence and recommendations on nutrition in cancer prevention, treatment and recovery, and provides recommendations for nutrition interventions. Lecture Objectives: -Identify nutrition and lifestyle guidelines for cancer prevention and prevention of cancer recurrence. -Describe the role of sound nutritional choices before, during, and after cancer therapy and how they can help increase energy levels, strengthen the immune system, fight off infection, and minimize the side effects of treatment. -Identify reasons for nutrition referral during treatment and the importance of early referrals at the start of treatment. This lecture was presented as part of the RN and Allied Health Lecture Series.
Jennifer Spring RD, CSO, LDN
3/8/2017 4:30:00 PM
View

Oncologic Emergencies - S. Bernard - 20160810
This lecture reviews emergency conditions seen in oncology and hematology patients and discusses the signs, symptoms and tests available for monitoring each of the emergency conditions. Learning Outcomes: • Describe the types of emergencies seen in oncology and hematology. • Explain the approaches to each emergent condition. • Discuss the types of monitoring and objectives of monitoring. This lecture was presented as a part of the RN and Allied Health Lectures.
Stephen Bernard MD
8/10/2016 3:30:00 PM
View

Optimizing Cancer Care: Updates for 2020 - B. Muluneh - 20201028
Dr. Benyam Muluneh from the UNC Eshelman School of Pharmacy will discuss relevant topics in cancer pharmacy for North Carolina cancer providers, such as adherence to oral anti-cancer therapies, evolving pharmaceutical practice models (e.g. specialized clinics), toxicity measurement and management, access, and other issues.
UNCCN Mediasite Presenter
10/28/2020 3:30:00 PM
View

Oral Chemotherapy: Overcoming the Challenge to Adherence - B. Muluneh - 20170412
As an increasing number of oral chemotherapy agents are being used, it is essential to understand the barriers that patients may face. This presentation discusses some of these barriers and offers advice for dealing with and overcoming them. The presented information details the dimensions of adherence, specifically in the context of the use of oral chemotherapy agents. Evidence-based strategies for assessing and improving adherence to oral chemotherapy, from health care system, plan of care and patient-level perspectives are provided. Lecture Objectives: -Discuss the shift from intravenous to oral chemotherapy over the past few decades. -Define the various dimensions of adherence. -Describe ways to manage patients who are non-adherent to oral chemotherapy. -Identify areas to advocate for legislation that can improve access to oral chemotherapy. This lecture was presented as part of the RN and Allied Health Lecture Series.
Benyam Muluneh PharmD, CPP
4/12/2017 3:30:00 PM
View

Outcomes Focused: Perioperative Management of Cancer Patients - D. L. James - 20181212
The talk discusses perioperative pain management techniques that can be utilized to decrease post-operative pain as well as development of chronic postoperative pain among cancer patients. For continuing education credits for this and other lectures, please visit our Learning Portal at learn.unc.org.
Dominika L James MD
12/12/2018 4:30:00 PM
View

Palliative Care Opportunities - N. Sartor - 20180711
This talk will address common myths of palliative and hospice care and explore multiple points along the health trajectory of a patient when a team might consider a palliative care consult. We will consider possible sources of suffering and interventions.
Nicole Sartor, RN,MSN,C-PNP-PC
7/11/2018 3:30:00 PM
View

Pediatric Oncology: Past, Present and Future Directions - S. Gold - 20151028
Dr. Stuart Gold, Chief of Staff of the UNC Pediatric Hematology/Oncology Division will discuss the important principles to understanding childhood cancer including the different types of pediatric cancer, pediatric oncology cooperative groups, ALL advances and the significant role that cytogenetics plays in ALL. Learning Outcomes: • Understand childhood cancer cooperative groups. • Understand childhood acute lymphoblastic leukemia and its treatment. • Understand where pediatric oncology has been and what the future may bring. This lecture was presented as a part of the Medical and Surgical Oncology Series
UNCCN Mediasite Presenter
10/28/2015 3:30:00 PM
View

Preparing Patients for Chemotherapy - T. Allred - 20190410
When a patient has received the life-changing news, she or he can feel overwhelmed by the need to digest the diagnosis while understanding and making decisions about sometimes rather complex treatment options. How do we plan and schedule the education for new chemo patients in a timely manner prior to the first day of chemo? What can we do to help the patient understand how the drugs work, what symptoms they can expect, and how they can deal with those symptoms?
UNCCN Mediasite Presenter
4/10/2019 3:30:00 PM
View

Professional Development and Continuing Education for Oncology Nurses - C. Gillet - 20190911
This lecture includes a review of professional development guidelines for Oncology Nurses, including education requirements for the State of North Carolina Board of Nursing. Claire Gillett will review favorite places to receive continuing education credits, as well as the UNC Lineberger Comprehensive Cancer Center’s/UNC Cancer Network’s RN education program and our 2019 schedule and list of topics.
Claire Gillett, RN, MSN, OCN
9/11/2019 3:30:00 PM
View

Radiation Oncology 101 - J. Camporeale and M. Knowles - 20190710
Radiation therapy can be used alone or in combination with chemotherapy in cancer treatment plans. This discussion will review the different forms of radiation therapy (including Proton Therapy, etc.), how it works, and how it can be used in combination with chemotherapy. Since radiation therapy has its own set of side effects, the speaker will address the most common symptoms (such issues as appetite loss and radiation mucositis) and how to help patients deal with them.
Jayne Camporeale MS,RN,OCN,APRN
7/10/2019 3:30:00 PM
View

Recent advances in Radiation Oncology . A. Z. Wang - 20191218
Radiotherapy plays an important part in many cancer treatment plans; however, recent studies suggest that we can make better use of radiotherapy in some instances. Dr. Andrew Wang, of Wang Laboratory at UNC Lineberger Comprehensive Cancer Center, will help us navigate this changing landscape.
UNCCN Mediasite Presenter
12/18/2019 4:30:00 PM
View

Safe Use of Dietary Supplements in Cancer Patients - A. Corbett - 20200909
Amanda Corbett, PharmD, BCPS, FCCP, will discuss recommendations regarding the use of supplements in patients with cancer. Safe use of THC and CBD will also be presented.
UNCCN Mediasite Presenter
9/9/2020 3:30:00 PM
View

Sickle Cell Disease: An Overview and Updates - K. Ataga - 20170125
The CDC estimates that Sickle Cell Disease affects approximately 100,000 Americans. This lecture will provide an overview of this group of inherited red blood cell disorders along with updates on current research in the field. Lecture Objectives: -Identify the various sickle cell syndromes. -Describe the pathophysiology of sickle cell disease. -Implement the NHLBI evidence-based guidelines for management of sickle cell disease. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Kenneth Ataga MBBS
1/25/2017 4:30:00 PM
View

The 7th Vital Sign: Identifying Malnutrition - M. Moyers - 20180411
Malnutrition can be a problem for cancer patients, since chemotherapy and/or radiation therapy might negatively affect a cancer patient’s appetite. This lecture discusses screening tools that are available to detect malnutrition and diagnose its extent.
UNCCN Mediasite Presenter
4/11/2018 3:30:00 PM
View

The Benefits of Exercise for Cancer Patients - G. Brennan - 20200108
Cardio-oncology is a newly expanding area of cancer rehabilitation in the exercise world. As a Clinical Exercise Physiologist part of the Cardiac Rehabilitation team, Gabrielle Brennan, MS, ACSM EP-C, CET, has a Master of Science in Exercise Physiology with a specialization in Cancer Care. Previously, she worked as an Exercise Specialist as the program director for the LiveFit Cancer Exercise Program. She will explore the program and numerous benefits patients gained from this program. The American College of Sports Medicine guidelines for cancer patients will also be discussed.
Gabrielle Brennan, MS, ACSM EP-C, CET
1/8/2020 4:30:00 PM
View

Understanding and Treating Anxiety & Depression in Patients and Families with Advanced Cancer - E. Park - 20181128
Dr. Park will review the presenting symptoms, diagnostic approach, and initial management of anxiety and depressive disorders in patients and families affected by cancer. She will additionally review challenges specific to the management of patients with advanced or terminal cancer. For continuing education credits for this and other lectures, please visit our Learning Portal at learn.unc.org.
Leeza Park MD
11/28/2018 4:30:00 PM
View

Understanding Oncology Drug Interactions - K. P. Morgan - 20181010
The narrow therapeutic index of oncology drugs makes understanding drug interactions critical for the safe and effective treatment of cancer patients. Small changes in the pharmacodynamics or pharmacokinetics of the drug can decrease efficacy or increase toxicity of the cancer drug potentially causing harm to patients during treatment.
Katherine Morgan, PharmD
10/10/2018 3:30:00 PM
View

Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform
Mediasite
Sonic Foundry